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Objectives. This study tested whether the combination of do-
butamine echocardiography (DE) and myocardial contrast echo-
cardiography (MCE) was superior to either technique alone in
identifying postischemic myocardium and in differentiating it
from necrotic myocardium.
Background. Wall motion abnormalities at rest occur in post-
ischemic myocardium in the presence of infarction, stunning or
hibernation, alone or in combination. Various investigators have
suggested that either DE or MCE can be used to identify the
presence of myocardial viability.
Methods. We studied a total of 53 mongrel dogs in an open
chest model of coronary occlusion of various durations followed by
reperfusion and dobutamine administration (10 mg/kg body
weight per min). MCE with aortic root injections of Albunex (area
under the curve) and DE (percent thickening fraction) were
performed at the different stages. Postmortem triphenyltetrazo-
lium chloride (TTC) staining was used to identify myocardial
necrosis.
Results. Thirteen dogs underwent brief (15 min) occlusions and
developed no necrosis (Group I). Of 40 dogs that underwent
prolonged (30 to 360 min) occlusions, 14 had no infarction (Group
II), whereas 26 did (Group III: 12 papillary muscle, 7 subendo-
cardial, 7 transmural). MCE (expressed as percent change from
baseline) demonstrated changes that paralleled the blood flow
changes observed by radiolabeled microspheres at all interven-
tions (r 5 0.67, p < 0.0001). Regional ventricular function
improved with dobutamine administration in the ischemic region
in all three groups. The sensitivity (88%) for detecting myocardial
viability was superior when the two techniques were combined;
however, a poor specificity (61%) was observed.
Conclusions. Contractile reserve and perfusion data are com-
plementary when assessing regional wall motion abnormalities in
postischemic myocardium. DE alone cannot differentiate postisch-
emic from infarcted myocardium; simultaneous data on myocar-
dial perfusion are required. The combination of DE and MCE is
superior to either technique alone for identifying the absence of
myocardial necrosis.
(J Am Coll Cardiol 1997;29:974–84)
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Early reperfusion (by means of thrombolysis or primary angio-
plasty, or both) in the setting of acute myocardial infarction
(MI) has resulted in the reduction of morbidity and mortality.
However, the success of either intervention has been difficult
to assess because wall motion abnormalities at rest in this
setting could relate to infarcted as well as postischemic or
hibernating myocardium, or both (1–5). To compound this
problem, the duration of ischemia could affect the degree of
postischemic recovery of function (6–7). Thus, diagnostic
techniques able to distinguish infarcted from noninfarcted, yet
asynergic, myocardium would be clinically useful. Various
investigators have previously suggested that myocardial con-
trast echocardiography (MCE) (8–15) and dobutamine echo-
cardiography (DE) (16–24) are useful techniques for identify-
ing the presence of myocardial viability in the setting of acute
MI. Whether these two techniques can be used to distinguish
necrotic from reperfused (postischemic) myocardium remains
to be determined.
Because differentiation between stunned, ischemic and
infarcted myocardium relies on the knowledge of myocardial
perfusion and potentially the degree of response to inotropic
stimulation, we hypothesized that the combination of MCE
(with its ability to demonstrate preserved myocardial perfu-
sion) and DE (with its ability to demonstrate contractile
reserve) is superior to either one individually in distinguishing
viable from nonviable myocardium and in distinguishing post-
ischemic dysfunction (i.e., “stunning,” from infarction of vari-
ous degrees of transmurality).
Methods
The study protocol conformed to the “Position of the
American Heart Association on Research Animal Use”
adopted by Association in November 1984 and was approved
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Surgical preparation. Fifty-three mongrel dogs weighing
29.5 6 4.7 kg (mean 6 SD) were anesthetized with 30 mg/kg
body weight of sodium pentobarbital intravenously (supple-
mented as necessary), intubated and artificially ventilated with
a Harvard respirator. Dogs were instrumented as previously
described by us (6,25–28). The heart was exposed through a
left thoracotomy and suspended in a pericardial cradle. A
cannula was placed in the left atrium to inject microspheres.
Catheters were placed in the carotid artery for continuous
blood pressure monitoring, in the femoral artery for micro-
sphere reference blood sampling, in the jugular vein for fluids
and drug administration and in the femoral artery to place a
modified pigtail catheter in the proximal aortic root just above
the aortic valve for administration of sonicated albumin.
The proximal left anterior descending (LAD) and left
circumflex (LCx) coronary arteries were dissected free, and silk
ties were loosely placed around them. Distal to the ties, a
Doppler flow velocity probe was placed snugly around each
vessel. Ties were used to occlude the LAD in 44 dogs and the
LCx in 9. Continuous recordings of arterial and pulmonary
artery pressure, electrocardiogram and Doppler flow velocity
signals were obtained using a five-channel strip chart recorder.
The chest cavity was filled with warm saline, and a ziplock bag
filled with saline was placed over the heart and used as an
acoustic interface. The echocardiographic short-axis slice im-
aged was identified with the use of an epicardial suture as
previously described (6,25–28).
Assessment of regional blood flow. Regional myocardial
blood flow (RMBF) was assessed with radiolabeled micro-
spheres (cerium-141, tin-113, scandium-46, ruthenium-103) as
previously described (6,25–29). One to two million spheres
were injected into the left atrium. Thirty seconds before
injection, reference blood was drawn at a constant rate of
4.5 ml/min. Withdrawal continued for 2.5 min after injection of
spheres. After the protocol, the reference blood and tissue
samples were counted in a gamma counter. RMBF was
calculated for each nuclide using the standard formula (29).
In this study, RMBF, at the different stages of the protocol,
was expressed as the percent change between events in the
ischemic region (i.e., baseline to coronary occlusion).
Myocardial contrast echocardiography. MCE was per-
formed as previously described (26–28). Briefly, 0.5 to 1.0 ml
of sonicated 5% human serum albumin (Albunex, Molecular
Biosystems, Inc.) was injected into the aortic root. The dose
that produced optimal myocardial opacification at baseline in
each dog was used and kept unchanged during the remainder
of the protocol (26–28). Three to five end-diastolic frames
were digitized before contrast injection, and enough frames
were placed on cine-loop format to allow the myocardial
contrast effect to pass and completely disappear from the
myocardium.
Assessment of regional myocardial perfusion by MCE.
Regional myocardial perfusion was analyzed with previously
described and validated on-line software (Acoustic Densitom-
etry, Sonos 1500, Hewlett-Packard) (28,30). This software
allows the operator to capture sequential end-diastolic frames
to analyze changes in intensity on-line with injection of echo
contrast medium. The computer subtracts the intensity values
(preinjection) from those obtained in the frames demonstrating
the contrast effect, constructing a time–intensity curve. As in
previous studies, (25,26,28) the area under the curve (AUC) was
used as the MCE variable of myocardial perfusion. The investi-
gator (M.F.M.) performing the MCE analysis had no knowledge
of the results of RMBF and regional myocardial function.
Regional function assessment. Quad screen cine loops of
digitized cardiac cycles were created with Freeland-Tomtec
software. Regional function (thickening fraction) was assessed
as described by Porter et al. (31). The advantage of thickening
fraction is that it allows not only for the differences in wall
thickness among dogs, but also for changes that occur with
ischemia and reperfusion (32). Regional function was assessed
in the center of the ischemic zone by an investigator (J.C.) with
no knowledge of the results of RMBF and MCE and to which
group the dogs belonged.
Tissue processing. After the experimental protocol, the
heart was removed from the chest. To identify each individual
coronary artery perfusion territory, the dual-perfusion tech-
nique was used (27). The coronary arteries were perfused
simultaneously at identical pressures with two dyes: macrodex
(transparent dye) into the artery perfusing the ischemic terri-
tory; monastral blue (blue dye) into the artery perfusing the
control territory, allowing macroscopic identification and mea-
surement of the perfusion territories of each coronary artery.
The heart sections paralleled the coronary sinus at dis-
tances of 1 cm toward the apex. The slice corresponding to the
echocardiographic region of interest was incubated for 20 to
30 min in triphenyltetrazolium chloride (TTC) (pH 7.4 at
38°C) (6) and then photographed. Results of staining were
classified as positive (absence of necrosis) or negative (necrotic
myocardium). Papillary muscle infarcts were those showing any
necrotic pale areas within the papillary muscle. Subendocardial
infarcts were those showing any necrosis by TTC in the
subendocardium (inner half of the myocardium). Transmural
infarcts were those showing any degree of subepicardial necro-
sis. To find the amount of tissue necessary to maintain
contractile reserve and baseline myocardial perfusion, the
Abbreviations and Acronyms
AUC 5 area under the curve
DE 5 dobutamine echocardiography
LAD 5 left anterior descending coronary artery
LCx 5 left circumflex coronary artery
MCE 5 myocardial contrast echocardiography (echocardiographic)
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary angioplasty
RMBF 5 regional myocardial blood flow
TTC 5 triphenyltetrazolium chloride
%D 5 percent change
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relation between amount of necrosis (percent area at risk),
perfusion and thickening was obtained.
The slice of tissue corresponding to the echocardiographic
region of interest was sectioned into six equidistant segments
to obtain a large number of radiolabeled microspheres per
tissue sample, a factor known to increase its reliability (29).
The resulting samples were then placed in the gamma counter
for quantitation of radioactivity and calculation of RMBF.
Assessment of myocardial necrosis. Sensitivities and spec-
ificities for identification of absence of myocardial necrosis
were calculated for MCE and DE (independently and in
combination). Myocardial necrosis was defined as the absence
of red staining by TTC in the postmortem analysis.
Absence of necrosis by MCE. The criterion for absence of
necrosis by MCE was return of myocardial perfusion within
20% of the preocclusion value of the AUC 1) after release of
the coronary occlusion or 2) during dobutamine administra-
tion. This criterion was selected on the basis of two findings:
Injection to injection variability of this variable previously
shown by us using the videointensity analysis system used in
this study (28); and a hypothesis that infarcted tissue might be
accompanied by a lower blood flow than control tissue, as
suggested by Gewirtz et al (33). Thus, for MCE, true positive
regions were considered those that demonstrated a return of
perfusion after release of the occlusion with or without dobut-
amine administration and had no myocardial necrosis by TTC
staining. True negative regions were considered those that
demonstrated no return of perfusion to within 20% of baseline
at release of the occlusion with or without dobutamine admin-
istration and had evidence of myocardial necrosis. False posi-
tive regions were considered those with return of perfusion at
release of the occlusion or during dobutamine administration,
yet demonstrated myocardial necrosis by TTC staining. False
negative regions were considered those with no return of
perfusion with or without dobutamine administration and no
evidence of myocardial necrosis at postmortem analysis.
Absence of necrosis by DE. Criteria for absence of necrosis
on regional function consisted of improvement in thickening
fraction ($10% based on reproducibility in 18 separated
measurements) after reperfusion in the ischemic region versus
the values observed during coronary occlusion. This improve-
ment was observed after reperfusion in 13 of 35 frankly
dyskinetic regions (10 became hypokinetic, 3 became normal).
For DE, true positive regions were considered those that
demonstrated improvement in thickening fraction after release
of the coronary occlusion with or without dobutamine admin-
istration and no evidence of myocardial necrosis by TTC
staining. True negative regions were considered those with no
improvement in thickening fraction, yet had evidence of ne-
crosis. False positive regions were considered those with im-
provement in thickening fraction and evidence of necrosis.
False negative regions were considered those without improve-
ment in thickening fraction and no evidence of myocardial
necrosis by TTC staining.
Absence of necrosis by MCE and DE combined. When the
two techniques were combined, true positive regions consisted
of those that demonstrated perfusion at levels within 10% of
baseline values or an increase in wall thickening after release
of the occlusion with or without dobutamine administration,
with no evidence of myocardial necrosis by TTC staining. True
negative regions were those with no return of perfusion and no
lessening of wall thickening at release of the occlusion with or
without dobutamine administration, with evidence of necrosis
by TTC staining. Finally, false positive and false negative regions
were those that met either set of criteria for each individual
technique, as previously described.
Protocol. Hemodynamic variables were constantly moni-
tored. After instrumentation, baseline injections of radiola-
beled microspheres and Albunex were performed in the left
atrium and aortic root, respectively. Intravenous lidocaine (1.5
to 2 ml/kg) was followed by occlusion of one coronary artery.
Absence of anterograde flow was confirmed by Doppler. A
second set of injections was performed 10 min after occlusion.
To create a model of short ischemia, occlusions were
released after 15 min (Group I, 13 dogs). To create models of
prolonged ischemia and infarction, occlusions were kept be-
tween 30 and 360 min (prolonged occlusion without [Group II,
14 dogs] and with infarction [Group III, 26 dogs]). Release of
occlusion was verified by Doppler. A third set of injections was
performed after 10 to 15 min of stable reperfusion. The last set
of injections was performed 30 min after reperfusion during
intravenous administration of 10 mg/kg per min of dobutamine.
The animals were killed with an overdose of potassium chlo-
ride. Assessment of regional function, myocardial perfusion
(by MCE) and RMBF was performed at baseline, after coro-
nary occlusion, after reperfusion and during intravenous ad-
ministration of dobutamine.
Statistical analysis. Linear regression analysis was per-
formed for RMBF by radiolabeled microspheres and AUC in
the region of interest, both expressed as percent change
between events and baseline. Analysis of variance for multiple
observations was performed between the different interven-
tions (baseline, occlusion, release, dobutamine) for each of the
measured variables (microspheres, MCE, wall thickening frac-
tion). Multivariate analysis of variance was used for compari-
son of variables at each different intervention for analysis of
repeated measures. Between-group mean values were com-
pared by post hoc tests. Sensitivities and specificities for DE
and MCE alone and in combination and their 95% confidence
intervals (using p-normal theory confidence interval estima-
tions) were calculated. Super Anova Version 1.11 software
(Abacus Concepts, Inc.) was used. Statistical significance was
established at p , 0.05.
Results
Hemodynamic variables (Table 1). Heart rate and mean
arterial pressure were stable during coronary occlusions. Com-
pared with baseline measurements, a significant decrease in
heart rate was observed during reperfusion, followed by a
significant increase during dobutamine infusion. A significant
decrease in pressure, compared with that at baseline, was
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observed during reperfusion, with a return to baseline values
when dobutamine was added.
Correlation between regional myocardial perfusion and
RMBF. A total of 126 paired measurements in 53 dogs were
available in the ischemic zone for comparison between RMBF
by radiolabeled microspheres and AUC, both expressed as
percent change (%D) between events in the ischemic region, as
previously described. The linear regression plot is shown in
Figure 1 (r 5 0.67, p , 0.0001).
Regional perfusion and function. Group I (Fig. 2, Tables 2
and 3). This model mimics the classic model of stunning (i.e.,
15-min occlusion followed by reperfusion) (34,35). All 14 dogs
demonstrated a normal contractile pattern and lack of perfu-
sion defects at baseline. As expected, during occlusion, a
significant decrease in RMBF was observed (%D 275 6 17
[mean 6 SD] from baseline). A similar decrease in AUC was
observed (%D 297 6 62), accompanied by the development of
severe wall motion abnormalities (wall thickening fraction
211 6 17%).
After release of the occlusion, an increase (i.e., reactive
hyperemia) in RMBF (%D 27 6 46, p , 0.0001 from baseline)
and AUC (%D 62 6 127, p , 0.0009 from baseline) was
observed. Regional function showed a significant improvement
compared with that during occlusion; however, significant
dysfunction persisted relative to baseline measurements (8.7 6
14% at release, p , 0.05 from baseline).
After dobutamine administration, further improvement in
function was noted with return to preocclusion levels (thick-
ening fraction 23 6 14%, p 5 NS from baseline). In this group,
6 (54%) of 11 dogs showed a return of function to preocclusion
levels during dobutamine administration. One dog developed
ventricular fibrillation requiring multiple defibrillations before
dobutamine administration. Thus, regional function was not
analyzed in this animal. TTC staining revealed no evidence of
myocardial necrosis in the perfusion territory of the occluded
vessel.
Group II (Fig. 3 and 4, Tables 2 and 3). Thirteen dogs
underwent prolonged occlusions (30 to 360 min), yet devel-
oped no evidence of infarction on TTC staining. One dog had
fibrillation and was not analyzed during dobutamine adminis-
tration. Significant decreases (%D from baseline) in RMBF
(%D 258 6 22), AUC (%D 5 269 6 26) and thickening
fraction (214 6 34%, p , 0.0001) were observed during
occlusion in the ischemic region. After release of the occlusion,
RMBF (%D 232 6 44, p 5 NS from baseline) and AUC (%D
218 6 94, p 5 NS) returned toward baseline values; however,
despite this return, the severe abnormality in function ob-
served during occlusion persisted (thickening fraction 211 6
20, p , 0.0001 from baseline).
During dobutamine administration, an increase in RMBF
(%D 42 6 82, p , 0.0009) and AUC (%D 100 6 18, p , 0.004)
from postrelease levels was seen. Improvement in thickening
fraction from postrelease levels was also observed (14 6 17%,
p , 0.0003 from release). However, a depressed function
prevailed when compared with preocclusion levels (p 5 NS);
only 7 (50%) of 14 dogs showed improvement in function to
preocclusion levels. TTC staining revealed no evidence of
myocardial necrosis in any dog in this group.
Group III (Fig. 5, Tables 2 and 3). Twenty-six dogs under-
going prolonged coronary occlusions (180 to 360 min) demon-
strated the presence of myocardial necrosis by TTC staining
(12 papillary muscle infarcts, 7 subendocardial infarcts, 7
transmural infarcts). Similar to the short-occlusion and pro-
longed ischemia groups, RMBF and AUC demonstrated a
significant decrease during occlusion (%D 267 6 16 and
281 6 22 from baseline, respectively), and thickening fraction
became severely impaired (211.8 6 24%, p , 0.0001 from
baseline). After release of the occlusion, RMBF and AUC
returned to preocclusion levels. No significant relation was
observed between the amount of necrosis (percent area at risk)
and perfusion during dobutamine administration (expressed in
absolute and relative terms compared with postreperfusion
function). Thickening fraction was significantly impaired com-
pared with that at baseline (27.5 6 22%, p , 0.0001).
During dobutamine administration, a marked hyperemic
response was observed by microspheres (%D 97 6 109) and
MCE (%D 45 6 15) compared with occlusion levels (p ,
0.0001); however, thickening fraction during dobutamine ad-
ministration remained severely impaired relative to that at
baseline (14 6 13%, p , 0.003). Two dogs with a papillary
muscle infarct and one with a transmural infarct were not
included in the analysis of function during dobutamine admin-
istration because they had fibrillation after release of occlu-
sion; the defibrillations could have affected ventricular func-
tion. Only 3 (12%) of 26 dogs showing an infarct demonstrated
Figure 1. Linear regression plot for all interventions studied for the
AUC by MCE on the x axis and blood flow by microspheres on the y
axis. Results are expressed as %D from baseline to occlusion (circles),
release (squares) and dobutamine administration (triangles). echo 5
echocardiography.
Table 1. Heart Rate and Mean Arterial Pressure in 53 Study Dogs
Baseline Occlusion Reperfusion Dobutamine
HR (beats/min) 140.9 6 23.4 134.0 6 23.4 125.6 6 27.5* 157 6 23.8†
MAP (mm Hg) 94.7 6 17.0 89.1 6 19.1 83.6 6 20.7* 94.2 6 19.3
*p , 0.05, baseline versus reperfusion. †p , 0.05, baseline versus dobut-
amine. Data presented are mean value 6 SD. HR 5 heart rate; MAP 5 mean
arterial pressure.
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recovery of function to baseline levels. No significant relation
was observed between the amount of necrosis (percent area at
risk) and the contractile reserve with dobutamine (expressed in
absolute and relative terms vs. postreperfusion function) (Fig. 6).
Transmurality of infarcts. Papillary muscle infarcts. Dur-
ing coronary occlusion in this subgroup of dogs, RMBF and
AUC decreased significantly in the ischemic region compared
with that at baseline (%D 258 6 15 and 277 6 22, respec-
tively). After release of occlusion, RMBF (%D 15 6 52, p ,
0.03) and AUC (%D 52 6 92, p , 0.001) increased. During
dobutamine administration, both showed an increase from
predobutamine levels (%D 83 6 107 and 114 6 19, p , 0.0001,
respectively).
In this subgroup, a decrease in percent thickening fraction
was seen during occlusion (p , 0.0001) and persisted through-
out the protocol. Although dobutamine administration im-
proved wall thickening fraction, it did not reach baseline levels.
Two dogs were not included in the analysis of function during
dobutamine administration because of ventricular fibrillations
requiring multiple cardioversions.
Subendocardial infarcts. During occlusion, RMBF and
AUC decreased from baseline levels (%D 270 6 170 and
288 6 15, respectively). After release, an insignificant increase
in RMBF (%D 27.2 6 44) and AUC (%D 254 6 50) was
observed. During dobutamine infusion, RMBF increased (%D
124 6 107, p , 0.0001 from baseline); however, no increase in
AUC was noted (%D 20.079 6 0.844, p 5 0.08). Wall
thickening fraction remained depressed after release (p 5
0.01) but returned to near preocclusion levels during dobut-
amine (p 5 0.49 from baseline).
Transmural infarcts. During occlusion, RMBF and AUC
decreased compared with baseline levels (%D 279 6 8 and
280 6 27, respectively). RMBF increased after release (%D
0.07 6 52, p 5 0.02), further increasing after dobutamine (%D
98 6 113, p 5 0.0001). However, AUC did not show a change
after release (%D 219 6 87, p 5 NS) or during dobutamine
(%D 219.8 6 64.5, p 5 NS). A decrease in thickening fraction
persisted after release (p 5 0.001) and remained abnormal
during dobutamine infusion. One dog was excluded from
analysis of function during dobutamine because ventricular
fibrillation after the occlusion was released.
Comparison between infarct subgroups. RMBF alone did
not allow differentiation among the three infarct subgroups. A
comparable decrease in AUC was seen during occlusion in the
subgroups (%D 258 6 15 for papillary, 279 6 8 for transmu-
ral and 272 6 17 for subendocardial infarcts, p 5 NS),
followed by insignificant hyperemia (%D 15 6 52 for papillary,
27 6 41 for subendocardial and 7 6 52 for transmural infarcts,
p 5 NS). Although hyperemia was accentuated by dobut-
amine, no significant differences among the subgroups were
observed (%D 83 6 107 for papillary, 124 6 107 for subendo-
cardial and 98 6 132 for transmural infarcts).
AUC demonstrated changes similar to RMBF during all
interventions only in the papillary muscle infarction group. In
contrast, the MCE results observed in the subendocardial and
transmural groups showed no noticeable hyperemia by MCE
Figure 2. MCE at the different experimental
stages in a dog subjected to a 15-min LAD
occlusion. Top left, At baseline, homogenous
myocardial opacification is observed. Top
right, During occlusion, a perfusion defect is
observed in the LAD territory. Bottom left,
During reperfusion, homogenous opacification
is again seen, and no perfusion defect is appre-
ciated. Bottom right, During dobutamine ad-
ministration, enhancement of the contrast ef-
fect is observed. TTC staining reveals no
necrosis.
Table 2. Percent Change From Baseline in Regional Myocardial Blood Flow and Perfusion Changes
by Myocardial Contrast Echocardiography in the Various Models Examined
Group (RMBF
at B)
B–Occlusion B–Release B–Dobutamine
RMBF MCE RMBF MCE RMBF MCE
I (1.27 6 0.37) 275 6 17 297 6 06 27 6 46* 62 6 127* 76 6 80*† 120 6 184*
II (0.95 6 0.29) 258 6 22 269 6 26 232 6 44‡ 217 6 94‡ 42 6 82*† 100 6 178*
III (1.04 6 0.79) 267 6 16 281 6 22 7 6 48§ 4 6 91¶ 97 6 101†§ 45 6 153*‡
*p , 0.001, ¶p , 0.01 versus occlusion. †p , 0.05 versus release. ‡p , 0.05 versus Group I. §p , 0.05 versus Group
II. Data presented are mean value 6 SD. B 5 baseline; MCE 5 myocardial contrast echocardiography; RMBF 5
regional myocardial blood flow (ml/g per min).
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after release of the occlusion or during dobutamine adminis-
tration, or both. Thus, MCE was able to distinguish between
the papillary muscle group and the subendocardial and trans-
mural groups after release of the coronary occlusion.
All subgroups demonstrated a significant decrease in wall
thickening during occlusion that persisted after release of the
occlusion. Despite this decrease, the papillary muscle infarc-
tion subgroup had slightly better wall thickening recovery after
release than the other two subgroups (p 5 0.04 vs. subendo-
cardial infarcts, p 5 0.05 vs. transmural infarcts). Compared
with preocclusion wall thickening values, only the subendocar-
dial infarct group demonstrated a near normal wall thickening
recovery with dobutamine stimulation.
Discussion
In 1935, Tennant and Wiggers (7) demonstrated a strong
relation between ischemia and the development of regional
wall motion abnormalities. More recent studies have shown
(34–38) that even relatively short occlusions (,15 min) fol-
lowed by reperfusion result in prolonged myocardial dysfunc-
tion (i.e., myocardial stunning). Characteristically, the stunned
myocardium recovers in hours, days or even weeks after the
initial ischemic insult (35). It is this rather slow recovery of
function that could potentially lead to an erroneous conclusion
that irreversible myocardial damage has occurred despite
adequate reperfusion. To circumvent this problem, one can use
techniques that can simultaneously demonstrate the presence
of normal or near normal perfusion (35) and recovery of
function during inotropic stimulation (34,39–41).
The present study was performed to critically examine
under experimental conditions the ability of MCE and DE,
independently and in combination, to determine the amount of
myocardium with potential for functional recovery after reper-
fusion (i.e., absence of necrosis) in a canine model of coronary
occlusions of varying duration.
MCE and DE in stunned myocardium. MCE has been
used to identify stunned myocardium in the post-MI period
(8,9,14,15). Using MCE in acute anterior MI, Ito et al. (8)
observed the no-reflow phenomenon (i.e., no evidence of
perfusion in the area at risk after reperfusion) in 9 patients and
restoration of perfusion in the remaining 30. At follow up, the
patients showing reflow after reperfusion showed a greater
Table 3. Regional Function (percent thickening fraction) in
Ischemic Zone During Interventions in Three Canine Models
Study Group Baseline Occlusion Reperfusion Dobutamine
I 24 6 11 210 6 16* 9 6 15 25 6 12†
II 23 6 07 214 6 33* 211 6 20 14 6 17†
III 29 6 20 212 6 24* 27 6 22 14 6 13†
*p , 0.05 from baseline. †p , 0.05 from release. Data presented are mean
value 6 SD.
Figure 3. MCE in a Group II dog subjected to
LAD occlusion. Top left, Homogenous myocar-
dial opacification is observed at baseline. Top
right, During occlusion, a perfusion defect is
observed in the LAD territory. Bottom left, Dur-
ing reperfusion, homogenous opacification is
again seen, and no perfusion defect is appreci-
ated. Bottom right, During dobutamine adminis-
tration, enhancement of the contrast effect is
observed. TTC staining reveals no necrosis.
Figure 4. Group II model. Two-dimensional echocardiographic im-
ages demonstrating a wall motion abnormality (from 11 to 3 o’clock)
developing after 4 h of LAD occlusion, which persists after release of
the occlusion. During dobutamine administration, an improvement in
function in the ischemic region can be observed.
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improvement in function than those showing no reflow. Agati
et al. (9) observed similar results in a group of patients studied
1 week post-MI.
Sabia et al. (14) observed an improvement in function in
patients with, but not in those without, collateral flow by MCE.
Furthermore, despite prolonged coronary occlusions, when
collateral flow is present, patients and animals exhibit marked
improvement in function after percutaneous transluminal cor-
onary angioplasty (PTCA) and thrombolysis, respectively
(6,15). In the current study, MCE in Group I documented a
significant decrease in flow during coronary occlusion, hyper-
emia after the release of the occlusion and a further increase in
flow in response to dobutamine administration, paralleling the
flow changes observed with radiolabeled microspheres. Thus,
our results confirm the value of MCE in documenting blood
flow changes in the classic setting of myocardial stunning.
In Group I, we observed regional dysfunction after restor-
ing adequate flow during reperfusion and improvement in
regional function during dobutamine administration. These
findings are characteristic of myocardial stunning and in
agreement with previous studies in dogs (24,32,34,35,38).
Pierard et al. (16) studied 17 patients treated with throm-
bolysis within 3 h of an acute MI. During dobutamine admin-
istration, patients found to have normal perfusion and glucose
uptake by positron emission tomography showed an improve-
ment in function in the asynergic regions and an improvement
in function at follow-up, suggesting that DE can identify viable
stunned myocardium. Marzullo et al. (17) studied 14 patients
with wall motion abnormalities at rest after MI. Correct
preoperative identification of myocardial viability (i.e., postop-
erative recovery of function) was achieved with DE in 82% of
viable segments and 92% of nonviable segments. Smart et al.
(18) studied 63 patients 2 days after MI. PTCA or coronary
artery bypass graft surgery was performed without knowledge
of the results of DE. Low dose DE correctly predicted
improvement in regional function in 19 of 22 patients. These
studies support the use of low dose dobutamine in detecting
stunned myocardium early after MI. As previously reported
(6,7), we observed a significant improvement in regional
function after reflow in Group I only, suggesting a relation
between duration of ischemia and degree of postischemic
recovery of function.
During coronary occlusion, we observed similar changes in
regional function in the short (Group I) and prolonged isch-
Figure 5. MCE in a Group III dog with
LAD occlusion (infarction). Top left, At
baseline, homogenous myocardial opacifi-
cation is seen. Top right, During occlusion,
a perfusion defect is observed in the LAD
territory. Bottom left, During reperfusion,
the perfusion defect continues to be evi-
dent. Bottom right, During dobutamine
administration, the perfusion defect is
more evident. TTC staining reveals a trans-
mural myocardial infarction.
Figure 6. Extent of necrosis (percent area at risk [AAR]) versus
thickening fraction and AUC during dobutamine administration. No
significant correlation is observed in either case. AN 5 area of
necrosis.
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emia (Group II) groups. However, after reperfusion function
remained more severely impaired in the prolonged ischemia
group. During dobutamine administration, regional function
improved in both groups after reperfusion.
Our data agree with previous data (13,16–18,20–22,42)
suggesting that myocardium subjected to short as well as
prolonged ischemia can potentially demonstrate an improve-
ment in function with dobutamine. However, to distinguish
between the short and the prolonged ischemia groups (and
from necrosis), simultaneous analysis of flow and perhaps
metabolism is required. Along these lines, a recent study by
Vanoverschelde et al. (43) suggests that wall motion abnor-
malities at rest in humans are more likely to be due to
repetitive stunning. This phenomenon could potentially ex-
plain the positive responses to dobutamine observed in studies
where “hibernation” was suspected, but no simultaneous flow
data were obtained. Thus, DE appears to be a very useful test
for identifying myocardial stunning.
MCE in prolonged ischemia. In the prolonged ischemia
group, a decrease from baseline in RMBF (58%) and perfu-
sion (69%) was observed during coronary occlusion by radio-
labeled microspheres and MCE, respectively. This decrease
was of a lesser magnitude than that observed in the infarction
and short-occlusion groups, suggesting that the prolonged
ischemia group had better collateral vessels and was able to
maintain myocardial viability despite prolonged occlusion
times. In this respect, the dogs in this group are similar to those
studied by Schultz et al. (44). After release of the occlusion,
flow and perfusion remained below baseline values as opposed
to the results observed in Group I, which, in the absence of
necrosis, suggests the “low reflow” phenomenon described by
Pryzklenk et al. (45). Thus, knowledge of flow and perfusion
helped separate Groups I and II.
During dobutamine administration, both flow and perfusion
increased in Groups I and II. The magnitude of this change
was greater in Group I than in Group II and suggests better
microvascular reserve with shorter, rather than longer, occlu-
sions; however, this did not reach statistical significance. This
finding has also been previously described by Pryzklenk et al. (45).
Dobutamine and MCE in infarctions. In the present study,
a marked decrease in regional function, similar to the short
and prolonged ischemia groups, occurred after coronary oc-
clusions in the infarct group. A trend toward worsening
regional function was observed as the extent of infarction
increased. After release of the occlusion, regional function
remained abnormal in all groups of infarcts, and no difference
in function was observed relative to Group 2. In contrast, a
significant difference between short occlusions and infarction
was observed. Dobutamine administration, after release of the
occlusion, resulted in a significant improvement in regional
function in papillary muscle and subendocardial infarcts but
did not allow separation between infarcts as a group from
Groups I and II.
Our data suggest that the presence of contractile reserve in
itself does not exclude the presence of regional necrosis. This
finding has also been reported by Sklenar et al. (13) in the dog
model. In their study, in some dogs with infarcts of consider-
able sizes (40% to 53%), dobutamine administration at the
dose we used in our study (10 mg/kg per min) resulted in an
improvement of percent wall thickening when compared with
occlusion and reflow values. Although, as a group, dogs with
smaller infarcts demonstrate a return of percent wall thicken-
ing to preocclusion levels during dobutamine infusion, a
significant degree of variability can be observed when the data
are analyzed in individual dogs.
The observation that dobutamine administration can elicit a
contractile response in infarcted myocardium has been repro-
duced in the clinical arena. In a recent study, Barilla et al. (19)
administered low dose dobutamine in 21 patients presenting
with an acute MI. All but one of the patients enrolled
demonstrated an improvement in wall motion score with
dobutamine administration. Only two patients with a Q wave
MI demonstrated functional improvement in the ischemic
zone at 40 6 15 days of follow-up, despite having demon-
strated improvement during dobutamine administration. All
but one of the patients who underwent revascularization had
functional improvement at follow-up. No improvement in
function was seen in medically treated patients. That study
exemplifies not only the benefits of revascularization after MI,
but it also illustrates the lack of specificity of the contractile
response elicited by dobutamine administration in the setting
of an MI.
One potential explanation for the improvement of regional
function that we observed in some subendocardial and trans-
mural infarcts may reside in our definition of these types of
infarcts (see “Assessment of myocardial necrosis”). Islands of
normal (or relatively normal) tissue coexisted with necrotic
tissue as assessed by TTC staining (Fig. 5). These islands of
viable tissue showed perfusion and thus were capable of
showing contractile reserve as well. This probably explains the
improved specificity observed when the use of perfusion data
was added to the data on regional function (Table 4). In
addition to this, a tethering effect from the subepicardium or
from normal adjacent areas to the ischemic zone, or both,
could have led to an improvement in regional function. In
contrast, the differentiation of short and prolonged ischemia
and infarction improved when a more strict definition of
myocardial viability (i.e., return of thickening fraction during
dobutamine administration to preocclusion values) was used.
Our data suggest that reactive hyperemia, immediately after
reperfusion, limits the use of quantitative data of myocardial
perfusion for the identification of necrosis. In this regard, our
data support the qualitative findings of Ito et al. (8) in humans.
These investigators found that despite the presence of an acute
MI, no perfusion abnormalities were visually identified after
successful reperfusion in 30 of 39 patients. Similarly, in a
previous study of myocardial perfusion patterns from our
laboratory (46) in the same group of animals as those used in
the present study, we visually observed perfusion abnormalities
early after reperfusion in only 13 of 26 dogs with infarction.
Our results suggest that hyperemia observed in response to
dobutamine administration is reduced in asynergic regions
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subjected to prolonged ischemia and infarction compared with
short ischemia. Furthermore, this response worsens as the
transmurality of infarction progresses, a finding that could be
explained by worsened microvascular reserve with more pro-
longed and severe ischemia. These results could potentially be
used to determine not only the severity of the ischemia, but the
amount of myocardium irreversibly injured.
Combined use of DE and MCE. The present study suggests
that the combination of DE and MCE can identify the causes
of myocardial asynergy (i.e., stunning vs. infarction) better
than either technique alone. However, the poor specificity of
the combination limits their potential clinical applicability.
The effect of an inotropic agent on contractile reserve was
found to decrease with longer ischemic insults independent of
the severity of underperfusion. The large variability in regional
function observed in response to dobutamine administration in
Group I dogs has previously been observed by other investi-
gators using other inotropes (47). This variability created
significant overlap with the response observed in the prolonged
ischemia and infarction groups and was the main reason for the
failure of dobutamine to effectively differentiate the three
groups studied.
Limitations of the study. We used a single dose of dobut-
amine (10 mg/kg per min) in the present study because this
dose has been found to be effective in determining the
presence of myocardial stunning in animals (13) and humans
(18,22). Afridi (22) and Smart et al. (18), in patients, and
Sklenar et al. (13), in dogs, found that dobutamine (#10 mg/kg
per min) correctly identified the majority of segments that
eventually showed an improvement in function. Although
potentially higher doses of dobutamine could have further
differentiated the three groups of animals studied, the safety of
this approach in the acute MI period needs further study.
Furthermore, loss in specificity could have resulted with higher
doses of dobutamine.
In the present study, unlike the clinical situation, no coro-
nary stenosis is present on relief of the coronary occlusion.
After successful thrombolysis or PTCA, or both, during acute
MI in humans, the severity of the stenoses can vary from mild
to critical. A severe stenosis could limit the reactive hyperemia
and thus potentially result in reduced regional flow in the
infarct zone. Thus, our data might apply to those patients in
whom the severity of the remaining stenoses does not limit
hyperemia.
The definition of absence of necrosis by MCE used in the
present study was based on the hypothesis that infarcted
segments would exhibit lower flow than viable segments, as
suggested by a recent study by Gewirtz et al. (33). In that study,
96% of viable regions had regional blood flow $0.39 ml/g per
min and .75% had flow .0.58 ml/g per min. However,
significant overlap of viable and nonviable segments has re-
cently been observed in a study of 14 patients with a previous
MI (48). Those investigators found that in 45% of segments
with wall motion abnormalities at the site of a previous MI,
baseline flow was not different from that in noninfarcted
segments. A better separation of viable and nonviable seg-
ments was observed only after dipyridamole administration,
when 84% of the viable segments (but only 20% of the
infarcted ones) maintained a normal coronary reserve. Thus,
our results are more in agreement with the latter study and
suggest that the presence of adequate rest perfusion after MI
does not rule out the presence of infarction.
Clinical implications. When evaluating regional wall mo-
tion abnormalities after reperfusion, knowledge of contractile
reserve, as well as perfusion data, is imperative to enhance
prediction of absence of necrosis and the etiology of the
underlying asynergy. The use of low dose dobutamine by itself
can lead to overestimation or underestimation of the presence
or absence of necrosis.
Conclusions. We conclude that although the combination
of low dose DE and MCE is superior to either technique alone
in differentiating necrotic from postischemic myocardium,
significant limitations for these techniques remain in this
setting. The ability of the combination of DE and MCE to offer
more accurate information in predicting functional recovery
than either technique alone after revascularization procedures
in patients with coronary artery disease remains to be investi-
gated.
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